drugset / Trial / NCT00809042
Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia
RandomizedFactorialDouble-blindTreatment
Summary
The purpose of this study is determination of the efficacy of combination of hydroxyurea with L-carnitine or magnesium in improving hematologic parameters and cardiac status in patients with β-thalassemia intermedia in comparison with hydroxyurea alone .
Timeline
- Start
- 2007-06
- Primary completion
- 2007-11
- Completion
- 2007-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydroxyurea | Other / unclassified | 10 mg/kg | — |
| Comparator | L-carnitine | Other / unclassified | 50 mg/kg | — |
| Comparator | MAGNESIUM CHLORIDE ANHYDROUS | Small molecule | 0.6 unknown | — |